Despite its benefits, pCR has limitations. It may not fully predict long-term outcomes for all patients, as some can achieve pCR but still experience a recurrence. Additionally, the definition of pCR can vary between clinical trials and institutions, potentially leading to inconsistencies. Moreover, achieving pCR does not guarantee the absence of micrometastases, which can lead to recurrence.